Drug
Frexalimab
Frexalimab: highest development phase Phase 3, developed by Sanofi. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Sanofi
Trials
| Drug | Phase | Indication |
|---|---|---|
| Frexalimab NCT06141486 | Phase 3 | Multiple Sclerosis |
| Frexalimab NCT06111586 | Phase 2 | Type 1 Diabetes Mellitus |
Latest
Follow Frexalimab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.